Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)

SFOSF Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 5, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,730	8,186	8,686	12,603	17,924	19,268
Market Cap Growth	24.31%	-5.76%	-31.08%	-29.69%	-6.98%	106.13%
Enterprise Value	14,938	12,438	12,583	15,964	21,251	22,626
Last Close Price	2.61	1.80	2.19	3.21	4.38	4.66
PE Ratio	21.10	21.57	25.82	23.30	24.08	34.34
PS Ratio	1.75	1.46	1.49	1.98	2.92	4.15
PB Ratio	1.14	1.00	1.09	1.61	2.35	2.74
P/TBV Ratio	3.01	2.73	2.89	3.99	5.83	6.40
P/FCF Ratio	216.24	894.58	-	-	-	-
P/OCF Ratio	14.22	13.35	18.04	20.61	28.92	48.76
EV/Sales Ratio	2.61	2.21	2.15	2.51	3.46	4.87
EV/EBITDA Ratio	19.49	16.47	22.98	19.87	32.27	36.18
EV/EBIT Ratio	42.03	30.53	75.34	32.19	53.22	56.42
EV/FCF Ratio	332.00	1359.25	-	-	-	-
Debt / Equity Ratio	0.60	0.60	0.62	0.56	0.53	0.52
Debt / EBITDA Ratio	6.93	6.07	8.44	5.25	5.86	5.63
Debt / FCF Ratio	114.65	539.31	-	-	-	-
Asset Turnover	0.34	0.36	0.38	0.44	0.44	0.38
Inventory Turnover	2.91	2.90	3.01	3.77	3.82	3.03
Quick Ratio	0.66	0.68	0.73	0.78	0.75	0.71
Current Ratio	0.92	0.92	1.00	1.06	1.04	1.01
Return on Equity (ROE)	6.75%	6.03%	5.23%	7.70%	10.55%	9.25%
Return on Assets (ROA)	1.32%	1.61%	0.67%	2.13%	1.79%	2.05%
Return on Invested Capital (ROIC)	2.44%	3.21%	1.47%	4.67%	3.56%	4.04%
Return on Capital Employed (ROCE)	3.00%	3.70%	1.50%	4.60%	4.00%	4.50%
Earnings Yield	4.74%	4.64%	3.87%	4.29%	4.15%	2.91%
FCF Yield	0.46%	0.11%	-3.12%	-1.92%	-0.91%	-1.48%
Dividend Yield	-	2.44%	1.74%	1.89%	2.02%	1.41%
Payout Ratio	63.02%	74.35%	102.89%	63.64%	40.48%	50.09%
Buyback Yield / Dilution	1.39%	-0.02%	-2.40%	-1.74%	-	-
Total Shareholder Return	1.39%	2.42%	-0.66%	0.16%	2.02%	1.41%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.